BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26826799)

  • 1. Design and synthesis of a novel class of carbonic anhydrase-IX inhibitor 1-(3-(phenyl/4-fluorophenyl)-7-imino-3H-[1,2,3]triazolo[4,5d]pyrimidin 6(7H)yl)urea.
    Kumari S; Idrees D; Mishra CB; Prakash A; Wahiduzzaman ; Ahmad F; Hassan MI; Tiwari M
    J Mol Graph Model; 2016 Mar; 64():101-109. PubMed ID: 26826799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening, molecular dynamics, and binding free energy calculations on human carbonic anhydrase IX catalytic domain for deciphering potential leads.
    John A; Sivashanmugam M; Umashankar V; Natarajan SK
    J Biomol Struct Dyn; 2017 Aug; 35(10):2155-2168. PubMed ID: 27373313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological evaluation of p-toluene sulphonylhydrazone as carbonic anhydrase IX inhibitors: An approach to fight hypoxia-induced tumors.
    Queen A; Khan P; Idrees D; Azam A; Hassan MI
    Int J Biol Macromol; 2018 Jan; 106():840-850. PubMed ID: 28830777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of novel pyridine-thiazolidinone derivatives as anticancer agents: Targeting human carbonic anhydrase IX.
    Ansari MF; Idrees D; Hassan MI; Ahmad K; Avecilla F; Azam A
    Eur J Med Chem; 2018 Jan; 144():544-556. PubMed ID: 29289880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel 4-(4-oxo-2-arylthiazolidin-3-yl)benzenesulfonamides as selective inhibitors of carbonic anhydrase IX over I and II with potential anticancer activity.
    Suthar SK; Bansal S; Lohan S; Modak V; Chaudhary A; Tiwari A
    Eur J Med Chem; 2013 Aug; 66():372-9. PubMed ID: 23827177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural study of interaction between brinzolamide and dorzolamide inhibition of human carbonic anhydrases.
    Pinard MA; Boone CD; Rife BD; Supuran CT; McKenna R
    Bioorg Med Chem; 2013 Nov; 21(22):7210-5. PubMed ID: 24090602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the interaction of a fluorescent antitumor sulfonamide with isozyme II and IX.
    Alterio V; Vitale RM; Monti SM; Pedone C; Scozzafava A; Cecchi A; De Simone G; Supuran CT
    J Am Chem Soc; 2006 Jun; 128(25):8329-35. PubMed ID: 16787097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis & biological evaluation of ferulic acid-based small molecule inhibitors against tumor-associated carbonic anhydrase IX.
    Aneja B; Queen A; Khan P; Shamsi F; Hussain A; Hasan P; Rizvi MMA; Daniliuc CG; Alajmi MF; Mohsin M; Hassan MI; Abid M
    Bioorg Med Chem; 2020 May; 28(9):115424. PubMed ID: 32209296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective inhibition of human carbonic anhydrases by novel amide derivatives of probenecid: synthesis, biological evaluation and molecular modelling studies.
    D'Ascenzio M; Carradori S; Secci D; Vullo D; Ceruso M; Akdemir A; Supuran CT
    Bioorg Med Chem; 2014 Aug; 22(15):3982-8. PubMed ID: 25027802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-tail approach to discovery of novel carbonic anhydrase IX inhibitors by simultaneously matching the hydrophobic and hydrophilic halves of the active site.
    Hou Z; Lin B; Bao Y; Yan HN; Zhang M; Chang XW; Zhang XX; Wang ZJ; Wei GF; Cheng MS; Liu Y; Guo C
    Eur J Med Chem; 2017 May; 132():1-10. PubMed ID: 28334643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New selective carbonic anhydrase IX inhibitors: synthesis and pharmacological evaluation of diarylpyrazole-benzenesulfonamides.
    Rogez-Florent T; Meignan S; Foulon C; Six P; Gros A; Bal-Mahieu C; Supuran CT; Scozzafava A; Frédérick R; Masereel B; Depreux P; Lansiaux A; Goossens JF; Gluszok S; Goossens L
    Bioorg Med Chem; 2013 Mar; 21(6):1451-64. PubMed ID: 23168081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. o-Benzenedisulfonimido-sulfonamides are potent inhibitors of the tumor-associated carbonic anhydrase isoforms CA IX and CA XII.
    Güzel-Akdemir Ö; Akdemir A; Isik S; Vullo D; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1386-91. PubMed ID: 23352754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
    Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
    Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-Activity Relationships of Benzenesulfonamide-Based Inhibitors towards Carbonic Anhydrase Isoform Specificity.
    Bhatt A; Mahon BP; Cruzeiro VW; Cornelio B; Laronze-Cochard M; Ceruso M; Sapi J; Rance GA; Khlobystov AN; Fontana A; Roitberg A; Supuran CT; McKenna R
    Chembiochem; 2017 Jan; 18(2):213-222. PubMed ID: 27860128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovering isozyme-selective inhibitor scaffolds of human carbonic anhydrases using structural alignment and de novo drug design approaches.
    Xiang F; Xiang J; Fang Y; Zhang M; Li M
    Chem Biol Drug Des; 2014 Feb; 83(2):247-58. PubMed ID: 24112770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sulfocoumarins (1,2-benzoxathiine-2,2-dioxides): a class of potent and isoform-selective inhibitors of tumor-associated carbonic anhydrases.
    Tars K; Vullo D; Kazaks A; Leitans J; Lends A; Grandane A; Zalubovskis R; Scozzafava A; Supuran CT
    J Med Chem; 2013 Jan; 56(1):293-300. PubMed ID: 23241068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and characterization of novel selective inhibitors of carbonic anhydrase IX.
    Dudutienė V; Matulienė J; Smirnov A; Timm DD; Zubrienė A; Baranauskienė L; Morkūnaite V; Smirnovienė J; Michailovienė V; Juozapaitienė V; Mickevičiūtė A; Kazokaitė J; Bakšytė S; Kasiliauskaitė A; Jachno J; Revuckienė J; Kišonaitė M; Pilipuitytė V; Ivanauskaitė E; Milinavičiūtė G; Smirnovas V; Petrikaitė V; Kairys V; Petrauskas V; Norvaišas P; Lingė D; Gibieža P; Capkauskaitė E; Zakšauskas A; Kazlauskas E; Manakova E; Gražulis S; Ladbury JE; Matulis D
    J Med Chem; 2014 Nov; 57(22):9435-46. PubMed ID: 25358084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.